Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidism
- PMID: 23943034
- PMCID: PMC4250040
- DOI: 10.1245/s10434-013-3190-4
Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidism
Abstract
Background: Many patients with primary hyperparathyroidism (PHPT) present with less severe biochemical parameters. The purpose of this study was to compare the presentation, operative findings, and outcomes of these patients with "mild" PHPT to patients with "overt" disease.
Methods: A retrospective review of a prospectively collected parathyroid database was performed to identify cases of PHPT undergoing an initial neck operation. Patients were classified as mild when either the preoperative calcium or PTH was within the normal limits. Comparisons were made with the Student's t test, Chi-squared test, or Wilcoxon rank-sum test where appropriate. Kaplan-Meier estimates were plotted for disease-free survival and compared by the log-rank test.
Results: Of the 1,429 patients who met inclusion criteria, 1,049 were classified as overt and 388 (27.1 %) were mild. Within the mild group, 122 (31.4 %) presented with normocalcemic PHPT and 266 (68.6 %) had a normal PTH. The two groups had similar demographics and renal function. Interestingly, the mild group had more than double the rate of kidney stones (3.1 vs. 1.3 %, p = 0.02). The mild group was less likely to localize on sestamibi scan (62.4 vs. 78.7 %, p < 0.01). Intraoperatively, more mild patients exhibited multigland disease (34.3 vs. 14.1 %, p < 0.01). When examining intraoperative PTH (IoPTH) kinetics where single adenomas were excised, the IoPTH fell at a rate of 6.9 pg/min in mild patients compared with 11.5 pg/min in the overt group (p < 0.01). Accordingly, 62.2 % of patients in the overt group and 53.3 % in the mild group were cured at 5 min postexcision (p < 0.01). There was no difference in the rates of persistence or recurrence between the groups, and disease-free survival estimates were identical (p = 0.27).
Conclusions: Patients with mild PHPT were more likely to have multigland disease and a slower decline in IoPTH, but these patients can be successfully treated with surgery.
Figures


Similar articles
-
Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease.Ann Surg Oncol. 2009 Dec;16(12):3450-4. doi: 10.1245/s10434-009-0699-7. Epub 2009 Sep 4. Ann Surg Oncol. 2009. PMID: 19760044
-
Surgical Management of Normocalcemic Primary Hyperparathyroidism and the Impact of Intraoperative Parathyroid Hormone Testing on Outcome.Otolaryngol Head Neck Surg. 2018 Oct;159(4):630-637. doi: 10.1177/0194599818793879. Epub 2018 Aug 14. Otolaryngol Head Neck Surg. 2018. PMID: 30105919
-
Minimal benefit to subsequent intraoperative parathyroid hormone testing after all four glands have been identified.Ann Surg Oncol. 2013 Dec;20(13):4200-4. doi: 10.1245/s10434-013-3188-y. Epub 2013 Aug 14. Ann Surg Oncol. 2013. PMID: 23943032
-
Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. long-term results.World J Surg. 2009 Nov;33(11):2256-65. doi: 10.1007/s00268-009-0166-4. World J Surg. 2009. PMID: 19763685 Review.
-
The role of intraoperative parathyroid hormone (IOPTH) determination for identification and surgical strategy of sporadic multiglandular disease in primary hyperparathyroidism (pHPT).Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101310. doi: 10.1016/j.beem.2019.101310. Epub 2019 Aug 8. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31409538 Review.
Cited by
-
PRIMARY HYPERPARATHYROIDISM - STRATEGY FOR MULTIGLAND DISEASE IN THE ERA OF SPECT-CT.Acta Endocrinol (Buchar). 2017 Jan-Mar;13(1):1-6. doi: 10.4183/aeb.2017.1. Acta Endocrinol (Buchar). 2017. PMID: 31149141 Free PMC article.
-
Primary hyperparathyroidism: predictors of sporadic multi-gland disease.Endocr Connect. 2024 Apr 4;13(5):e230492. doi: 10.1530/EC-23-0492. Print 2024 May 1. Endocr Connect. 2024. PMID: 38513354 Free PMC article. Review.
-
Improving diagnostic recognition of primary hyperparathyroidism with machine learning.Surgery. 2017 Apr;161(4):1113-1121. doi: 10.1016/j.surg.2016.09.044. Epub 2016 Dec 15. Surgery. 2017. PMID: 27989606 Free PMC article.
-
Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.J Endocrinol Invest. 2015 May;38(5):577-93. doi: 10.1007/s40618-015-0261-3. Epub 2015 Mar 28. J Endocrinol Invest. 2015. PMID: 25820553 No abstract available.
-
Use of the gamma probe to identify multigland disease in primary hyperparathyroidism.Int J Endocr Oncol. 2016 Feb;3(1):13-19. doi: 10.2217/ije.15.27. Int J Endocr Oncol. 2016. PMID: 27127604 Free PMC article.
References
-
- Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007;92(8):3001–3005. - PubMed
-
- Adler JT, Sippel RS, Chen H. New trends in parathyroid surgery. Curr Probl Surg. 2010;47(12):958–1017. - PubMed
-
- Chen H. Radioguided Parathyroid surgery. Adv Surg. 2004;38:377–392. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous